Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Current standards of treatment in ms and the role of oral agents.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Ultrasonographic diagnosis of demyelinating neuropathy.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system.
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
On the role of natural killer cells in neurodegenerative diseases.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Perception of muscular effort in multiple sclerosis.
Ambulation in adults with central neurologic disorders.
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Masquerading optic neuritis.
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.
Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Early Postnatal Myelin Content Estimate of White Matter via T1w/T2w Ratio.
Pages
« first
‹ previous
…
484
485
486
487
488
489
490
491
492
…
next ›
last »